Episode 816: Medicus Pharma ($MDCX) Chairman Discusses Promising Phase 2 SkinJect Results

from Stocks To Watch · host Global One Media Pte. Ltd.

This interview is disseminated on behalf of Medicus Pharma Ltd.In this episode of Stocks to Watch, we are joined by Medicus Pharma (NASDAQ: MDCX) Executive Chairman and CEO Dr. Raza Bokhari to discuss the company's promising Phase 2 results for SkinJect, its innovative skin cancer treatment, and what lies ahead for the company across oncology, rare diseases, and prostate cancer.Learn more about Medicus Pharma: https://medicuspharma.com/Watch the full YouTube interview here: https://youtu.be/4GZIBnS2KZ0And follow us to stay updated: https://www.youtube.com/GlobalOneMedia

Episode metadata supplied by the publisher feed · Published May 18, 2026

Embed this episode

Attribution link and audio player

Ready to play

Episode 816: Medicus Pharma ($MDCX) Chairman Discusses Promising Phase 2 SkinJect Results

0:00 16:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Stocks To Watch?

This episode is 16 minutes long.

When was this Stocks To Watch episode published?

This episode was published on May 18, 2026.

Can I download this Stocks To Watch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!